SHNXY (Shandong Xinhua Pharmaceutical Co) Cyclically Adjusted FCF per Share: $0.26 (As of Mar. 2026)


SHNXY Shandong Xinhua Pharmaceutical Co Ltd SHNXY
75 GF Score
Price $18.19
GF Value $21.89
! 5 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co Cyclically Adjusted FCF per Share?

Shandong Xinhua Pharmaceutical Co SHNXY 75 Cyclically Adjusted FCF per Share is $0.26 as of Mar. 2026. GuruFocus rates SHNXY with a GF Score™ of 75/100 and a GF Value™ of $21.89. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shandong Xinhua Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.299. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.26 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Shandong Xinhua Pharmaceutical Co was 18.30% per year. The lowest was -71.00% per year. And the median was 5.90% per year.

As of today (2026-07-08), Shandong Xinhua Pharmaceutical Co's current stock price is $18.19. Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $0.26. Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 69.96.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shandong Xinhua Pharmaceutical Co was 3860.00. The lowest was 56.90. And the median was 82.37.


Shandong Xinhua Pharmaceutical Co  (OTCPK:SHNXY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=18.19/0.26
=69.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shandong Xinhua Pharmaceutical Co was 3860.00. The lowest was 56.90. And the median was 82.37.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.08 0.17 0.23 0.27

Shandong Xinhua Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.27 0.26 0.27 0.26

SHNXY vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


SHNXY
75GF Score
Shandong Xinhua Pharmaceutical Co Ltd SHNXY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Xinhua Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.299/116.3033*116.3033
=-0.299

Current CPI (Mar. 2026) = 116.3033.

Shandong Xinhua Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.015 101.400 -0.017
201609 0.266 102.400 0.302
201612 0.250 102.600 0.283
201703 -0.202 103.200 -0.228
201706 -0.128 103.100 -0.144
201709 0.289 104.100 0.323
201712 0.381 104.500 0.424
201803 -0.184 105.300 -0.203
201806 0.217 104.900 0.241
201809 -0.242 106.600 -0.264
201812 0.059 106.500 0.064
201903 -0.077 107.700 -0.083
201906 0.065 107.700 0.070
201909 -0.039 109.800 -0.041
201912 0.009 111.200 0.009
202003 0.126 112.300 0.130
202006 0.077 110.400 0.081
202009 0.276 111.700 0.287
202012 -0.149 111.500 -0.155
202103 0.091 112.662 0.094
202106 0.043 111.769 0.045
202109 -0.023 112.215 -0.024
202112 -0.087 113.108 -0.089
202203 -0.197 114.335 -0.200
202206 0.355 114.558 0.360
202209 -0.074 115.339 -0.075
202212 0.976 115.116 0.986
202303 -0.506 115.116 -0.511
202306 0.282 114.558 0.286
202309 -0.050 115.339 -0.050
202312 0.130 114.781 0.132
202403 -0.030 115.227 -0.030
202406 -0.010 114.781 -0.010
202409 0.250 115.785 0.251
202412 0.099 114.893 0.100
202503 -0.075 115.116 -0.076
202506 0.423 114.907 0.428
202509 0.126 115.471 0.127
202512 0.415 115.832 0.417
202603 -0.299 116.303 -0.299

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.26 mean?
Shandong Xinhua Pharmaceutical Co (SHNXY) has a Cyclically Adjusted FCF per Share of $0.26 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors.
Is Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Shandong Xinhua Pharmaceutical Co's current Cyclically Adjusted FCF per Share is $0.26. Overall, Shandong Xinhua Pharmaceutical Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share of $0.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors. Shandong Xinhua Pharmaceutical Co's current Cyclically Adjusted FCF per Share is $0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Xinhua Pharmaceutical Co stock overvalued right now?
Shandong Xinhua Pharmaceutical Co (SHNXY) has a current Cyclically Adjusted FCF per Share of $0.26. The stock's GF Value™ is $21.89, compared to a current price of $18.19 — trading 16.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.26. Shandong Xinhua Pharmaceutical Co's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Shandong Xinhua Pharmaceutical Co (SHNXY), the current Cyclically Adjusted FCF per Share is $0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Xinhua Pharmaceutical Co (SHNXY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of $18.19 is trading 16.9% below its estimated GF Value™ of $21.89.

Key valuation signals for SHNXY:

  • Cyclically Adjusted FCF per Share: $0.26
  • GF Value™: $21.89 vs. price of $18.19 (16.9% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the SHNXY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Xinhua Pharmaceutical Co Business Description

Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
75GF Score

Get the complete analysis for SHNXY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.19
Price
$21.89
GF Value